Skip to contents Skip to Global Navigation Menu
  • KDCA
  • Contact us
  • E-Submission

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS. pISSN: 2210-9099. eISSN: 2233-6052

Page Path

1
results for

"Malachy I. Okeke"

Article category

Keywords

Publication year

Authors

"Malachy I. Okeke"

Original Article
Phylogenetic and genome-wide mutational analysis of SARS-CoV-2 strains circulating in Nigeria: no implications for attenuated COVID-19 outcomes
Daniel B. Kolawole, Malachy I. Okeke
Osong Public Health Res Perspect 2022;13(2):101-113.
Published online April 22, 2022
DOI: https://doi.org/10.24171/j.phrp.2021.0329
Phylogenetic and genome-wide mutational analysis of SARS-CoV-2 strains circulating in Nigeria: no 
implications for attenuated COVID-19 outcomes
Objectives
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). The COVID-19 incidence and mortality rates are low in Nigeria compared to global trends. This research mapped the evolution of SARS-CoV-2 circulating in Nigeria and globally to determine whether the Nigerian isolates are genetically distinct from strains circulating in regions of the world with a high disease burden. Methods: Bayesian phylogenetics using BEAST 2.0, genetic similarity analyses, and genomewide mutational analyses were used to characterize the strains of SARS-CoV-2 isolated in Nigeria. Results: SARS-CoV-2 strains isolated in Nigeria showed multiple lineages and possible introductions from Europe and Asia. Phylogenetic clustering and sequence similarity analyses demonstrated that Nigerian isolates were not genetically distinct from strains isolated in other parts of the globe. Mutational analysis demonstrated that the D614G mutation in the spike protein, the P323L mutation in open reading frame 1b (and more specifically in NSP12), and the R203K/ G204R mutation pair in the nucleocapsid protein were most prevalent in the Nigerian isolates. Conclusion: The SARS-CoV-2 strains in Nigeria were neither phylogenetically nor genetically distinct from virus strains circulating in other countries of the world. Thus, differences in SARS-CoV-2 genomes are not a plausible explanation for the attenuated COVID-19 outcomes in Nigeria.

Citations

Citations to this article as recorded by  Crossref logo
  • COVID19 Sero-epidemiology and vaccine uptake in two Southern Nigerian clinics
    Chinedu A. Ugwu, Ooreofe Odebode, Israel O. Ajayi, Josiah Olubunmi, Bejide Ifeoluwa, Jolly A. Adole, Kazeem Akano, Johnson Okolie, Philomena Eromon, Imonikhe K. Kio, Judith Amadi, Precious F. Adebayo, Iheanyi Mgbeokwere, Akeem O. Lawal, Olayemisi A. Adego
    PLOS Global Public Health.2026; 6(3): e0006126.     CrossRef
  • A retrospective whole genome sequencing of SARS-CoV-2 isolate from respiratory sample of an individual from Ota – Ogun State, Nigeria
    Olajumoke Olufunmilayo Joseph, Samuel Olatunde Dahunsi, Anthony Okoh
    Gene Reports.2024; 37: 102032.     CrossRef
  • 8,650 View
  • 95 Download
  • 2 Web of Science
  • Crossref
Page of 1